Tech startups such as Lio, Levitate, Minnesota Medical Technologies, among others, have announced their venture capital funding to bolster innovation and business growth.
Lio Raises $30 mn
AI procurement platform Lio (formerly askLio) announced a $30 million Series A funding round led by Andreessen Horowitz (a16z) with participation from SV Angels, Harry Stebbings, and Y Combinator. The company was founded by Shashank Aggarwal and Dhruv Agarwala to build an agentic AI platform that automates enterprise procurement workflows. Lio’s technology uses autonomous AI agents to manage sourcing, vendor communication, contract analysis, and purchasing decisions. The VC funding will accelerate product development and support expansion into the U.S. enterprise market. Strategically, the investment reflects growing venture capital interest in AI-driven enterprise automation platforms that reduce procurement costs and improve operational efficiency for large organizations.
Levitate Raises $16 mn
Customer engagement technology company Levitate announced it has secured $16 million in new venture funding led by Harbert Growth Partners, with participation from Northwestern Mutual Future Ventures and Bull City Venture Partners. Founded by Jesse Lipson, Levitate develops an AI-driven relationship marketing platform used by more than 8,000 businesses to automate personalized communication across email, social media, and messaging channels. The new VC funding will support product innovation and expansion of AI capabilities that help businesses strengthen client relationships and drive customer retention. Strategically, investors see strong potential in Levitate’s platform as companies increasingly adopt AI-powered marketing automation technologies to scale engagement and improve revenue growth.
Minnesota Medical Technologies Raises $20.6 mn
Minnesota Medical Technologies Corporation announced it has raised $20.6 million in Series A funding, co-led by HM Venture Partners and Southeast Minnesota Capital Partners. The company is led by founder and CEO Troy Simonson and focuses on developing innovative medical technologies addressing fecal incontinence and continence care solutions. The funding will support the commercial launch of its flagship product in the U.S. market, expand manufacturing capabilities, and accelerate clinical adoption. Strategically, the investment highlights venture capital interest in medtech innovations that improve patient care and quality of life. The capital infusion will enable the company to scale operations and advance next-generation healthcare device technology.
THASNIYA VP
